Drug Co. Celladon Faces Stock Drop Suit After CEO's Exit
By Bonnie Eslinger ( July 13, 2015, 5:16 PM EDT) -- Pharmaceutical maker Celladon Corp. and two executives were sued in California federal court on Friday for allegedly misleading shareholders and boosting stock prices that plummeted after the CEO resigned and the company announced it was suspending development of its heart therapy drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.